Evidence map›Paper›PMID 40444216›Full record

ArticleEuropean heart journal open2025

Prevalence of albuminuria and its association with left atrial remodelling in patients with atrial fibrillation.

Koki Nakanishi, Masao Daimon, Katsuhito Fujiu, Kentaro Iwama, Kazutoshi Hirose, Yuriko Yoshida, Yasuhiro Mukai, Hikari Seki, Yuko Yamamoto, Megumi Hirokawa and 10 more

Abstract read
In one paragraph

Article in European heart journal open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Koki NakanishiDepartment of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.ORCID https://orcid.org/0000-0002-5787-8004
Masao DaimonDepartment of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.ORCID https://orcid.org/0000-0002-7616-3477
Katsuhito FujiuDepartment of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.ORCID https://orcid.org/0000-0002-1889-9291
Kentaro IwamaDepartment of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.ORCID https://orcid.org/0000-0002-5673-5829
Kazutoshi HiroseDepartment of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.ORCID https://orcid.org/0000-0002-7084-9830
Yuriko YoshidaDepartment of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Yasuhiro MukaiDepartment of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.ORCID https://orcid.org/0000-0002-7218-385X
Hikari SekiDepartment of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Yuko YamamotoDepartment of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Megumi HirokawaDepartment of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Tomoko NakaoDepartment of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.ORCID https://orcid.org/0000-0002-4285-1888
Tsukasa OshimaDepartment of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.ORCID https://orcid.org/0000-0002-0431-4934
Takumi MatsubaraDepartment of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.ORCID https://orcid.org/0000-0002-8946-2695
Yu ShimizuDepartment of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.ORCID https://orcid.org/0009-0001-0167-5371
Gaku OguriDepartment of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.ORCID https://orcid.org/0000-0002-1386-8293
Toshiya KojimaDepartment of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.ORCID https://orcid.org/0000-0002-8879-0398
Eriko HasumiDepartment of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.ORCID https://orcid.org/0000-0003-1804-3466
Hiroyuki MoritaDepartment of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Makoto KuranoDepartment of Clinical Laboratory, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.ORCID https://orcid.org/0000-0002-2596-1145
Norihiko TakedaDepartment of Cardiovascular Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: Although recent epidemiological studies identified albuminuria as an independent risk for atrial fibrillation (AF), even in individuals with a preserved or mildly reduced estimated glomerular filtration rate (eGFR), the prevalence of albuminuria and its association with left atrial (LA) remodelling in patients with AF remains unknown. This study aimed to investigate the association of albuminuria with LA structure and mechanics before and after catheter ablation (CA) in AF patients. Methods and results: We examined 133 AF patients with an eGFR ≥60 mL/min/1.73 m Conclusion: Approximately 16% of AF patients with preserved or mildly reduced eGFR had albuminuria. The presence of albuminuria was related to unfavourable LA remodelling and its persistence even after restoration of sinus rhythm.

Indexed as

albuminuriaAtrial fibrillationLeft atrial remodelling

Identifiers

PMID40444216
PMCPMC12120667

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.